ROSE-010

N/A

Report date: 2024/10/09 20:00:32

Base Information

Drug NameROSE-010
Drug Alias NameROSE-010GTP-010LY-307161 SR
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsOverweightObesityIrritable Bowel Syndrome +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSwedenDenmark
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And CompanyBelrose Pharma
China Registration ClassN/A

Develop Information

Active CompaniesRose PharmaEli Lilly And Company
Inactive CompaniesRose Pharma AsUppsala UniversityMayo Clinic
Active IndicationsOverweightObesity
Inactive IndicationsIrritable Bowel SyndromeGastrointestinal Diseases

Other Information

ATC CodeN/A
Related LinksN/A